Shenzhen Qianhai Zhongke Zhibo Capital Management

The firm's name indicates affiliation with the Chinese Academy of Sciences research network, providing a proprietary channel into commercialization-stage companies emerging from CAS-affiliated labs, universities, and spinouts. This sourcing model differs from conventional venture capital by embedding the manager within an existing institutional infrastructure of patent portfolios and government-funded research programs.

Zhongke Zhibo focuses on early-stage venture and growth-equity positions, typically involving seed, Series A, or follow-on rounds for companies moving from research prototype to commercial production. The precise stage boundaries depend on the underlying technology's readiness level and the capital requirements of scaling manufacturing capacity.

The firm operates as a third-party private equity manager, not a single family office. Its Qianhai registration and CAS affiliation suggest capital sources may include government guidance funds, institutional investors, and qualified individual participants rather than a single family's wealth.

Confirmed sectors include semiconductor fabrication equipment, advanced materials, precision manufacturing, and biotechnology — all aligned with China's strategic technology self-sufficiency priorities and areas where CAS laboratories hold competitive intellectual property positions.

The firm likely participates in co-investment structures alongside other CAS-affiliated funds, provincial government guidance funds, and possibly Hong Kong-domiciled vehicles via the Qianhai zone's cross-border investment channels. Specific co-investment partners are not publicly disclosed.